Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
49,592,111
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
34,429,035
-
Shares change
-
+2,650,212
-
Total reported value, excl. options
-
$385,950,468
-
Value change
-
+$30,431,109
-
Number of buys
-
51
-
Number of sells
-
29
-
Price
-
$11.21
Institutional Holders of Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA) as of Q2 2025
As of 30 Jun 2025 Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA) had 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,429,035 shares of stock of the company.
Largest 10 holders included FMR LLC, VR ADVISER, LLC, Fairmount Funds Management LLC, BlackRock, Inc., RTW INVESTMENTS, LP, Deep Track Capital, LP, VANGUARD GROUP INC, BRAIDWELL LP, Commodore Capital LP, and FRANKLIN RESOURCES INC.
This table shows 96 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.